Veterinary Medicines

BIOFEL PCHR ενέσιμο γαλάκτωμα για γάτες

Authorised
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
  • Felid herpesvirus 1, strain FHV-1 Bio-9, Inactivated
  • Feline calicivirus, strain FCV F9 Bio-8, Inactivated
  • Feline panleucopenia virus, strain FPV Bio 7, Inactivated
Download as PDF

Product identification

Medicine name:
BIOFEL PCHR ενέσιμο γαλάκτωμα για γάτες
Active substance:
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
  • Felid herpesvirus 1, strain FHV-1 Bio-9, Inactivated
  • Feline calicivirus, strain FCV F9 Bio-8, Inactivated
  • Feline panleucopenia virus, strain FPV Bio 7, Inactivated
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabies virus, strain SAD Vnukovo-32, Inactivated
    1.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Felid herpesvirus 1, strain FHV-1 Bio-9, Inactivated
    100000.00
    50% tissue culture infectious dose
    /
    1.00
    millilitre(s)
  • Feline calicivirus, strain FCV F9 Bio-8, Inactivated
    316228.00
    50% tissue culture infectious dose
    /
    1.00
    millilitre(s)
  • Feline panleucopenia virus, strain FPV Bio 7, Inactivated
    1000.00
    50% tissue culture infectious dose
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cat
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AA09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 69249/19-06-2025/K-0267001
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 9/08/2023
Updated on: 10/08/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 9/08/2023
Updated on: 10/08/2023
Download